Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection

Árpád Farkas, Annamária Szipőcs, Alpár Horváth, I. Horváth, Gabriella Gálffy, János Varga, Kristóf Galambos, Szilvia Kugler, A. Nagy, Zsuzsanna Szalai

Research output: Contribution to journalArticle

Abstract

Introduction: Drug emission from DPIs is dependent on the inspiratory flow parameters through them, which are not directly measured by standard spirometry. Their estimation based on native spirometric data could help in choosing the appropriate device and optimizing the drug deposition. Objectives: The aim of this study was to survey patient preferences and to find correlations between breathing parameters of COPD patients through DPI devices and their baseline spirometric data, age, gender, disease severity and anthropometric characteristics. Another objective was to establish relationships between peak inspiratory flows (PIFdev) through Breezhaler®, Genuair® and Turbuhaler® inhalers and their determinants. Methods: Breathing parameters of 49 patients with previously diagnosed COPD and currently using one of the above inhalers were recorded by normal spirometry and while inhaling through the selected DPIs. Statistical analysis of the measured data was completed. All specific data are provided as (mean ± standard deviation). Results: More than 60% of the patients stated that their current device is the easiest to use. The means of the measured PIFdev values were 91.4 L/min, 77.1 L/min and 77.5 L/min for Breezhaler®, Genuair®, and Turbuhaler®, respectively. PIFdev values were significantly higher for males than for females, but differences upon age, BMI and disease severity group were not significant (at p = 0.05). Peak inspiratory flows through the inhalers (PIFdev) correlated best with their native spirometric counterparts (PIF) and linear PIFdev-PIF relationships could be determined (Breezhaler®: r = 0.60, p = 0.002, Genuair®: r = 0.55, p = 0.001, Turbuhaler®: r = 0.57, p = 0.002). Physical background of the deduced equations was also provided. Conclusions: Present correlations may be used to assess the success of inhalation of COPD patients through the studied devices and to choose the appropriate device for each patient. As a consequence, the amount of the drug emitted by the device can be optimized, the deposition efficiency within the lungs increased and the related therapeutic effect improved.

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalRespiratory Medicine
Volume154
DOIs
Publication statusPublished - Jul 1 2019

Fingerprint

Nebulizers and Vaporizers
Equipment and Supplies
Chronic Obstructive Pulmonary Disease
Spirometry
Inhalation
Respiration
Pharmaceutical Preparations
Statistical Data Interpretation
Patient Preference
Therapeutic Uses
Lung

Keywords

  • Management of COPD patients
  • Patient and device specific spirometric parameters
  • Personalized device selection

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection. / Farkas, Árpád; Szipőcs, Annamária; Horváth, Alpár; Horváth, I.; Gálffy, Gabriella; Varga, János; Galambos, Kristóf; Kugler, Szilvia; Nagy, A.; Szalai, Zsuzsanna.

In: Respiratory Medicine, Vol. 154, 01.07.2019, p. 133-140.

Research output: Contribution to journalArticle

Farkas, Árpád ; Szipőcs, Annamária ; Horváth, Alpár ; Horváth, I. ; Gálffy, Gabriella ; Varga, János ; Galambos, Kristóf ; Kugler, Szilvia ; Nagy, A. ; Szalai, Zsuzsanna. / Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection. In: Respiratory Medicine. 2019 ; Vol. 154. pp. 133-140.
@article{9227c6022e894b52b26c0117edec0d6c,
title = "Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection",
abstract = "Introduction: Drug emission from DPIs is dependent on the inspiratory flow parameters through them, which are not directly measured by standard spirometry. Their estimation based on native spirometric data could help in choosing the appropriate device and optimizing the drug deposition. Objectives: The aim of this study was to survey patient preferences and to find correlations between breathing parameters of COPD patients through DPI devices and their baseline spirometric data, age, gender, disease severity and anthropometric characteristics. Another objective was to establish relationships between peak inspiratory flows (PIFdev) through Breezhaler{\circledR}, Genuair{\circledR} and Turbuhaler{\circledR} inhalers and their determinants. Methods: Breathing parameters of 49 patients with previously diagnosed COPD and currently using one of the above inhalers were recorded by normal spirometry and while inhaling through the selected DPIs. Statistical analysis of the measured data was completed. All specific data are provided as (mean ± standard deviation). Results: More than 60{\%} of the patients stated that their current device is the easiest to use. The means of the measured PIFdev values were 91.4 L/min, 77.1 L/min and 77.5 L/min for Breezhaler{\circledR}, Genuair{\circledR}, and Turbuhaler{\circledR}, respectively. PIFdev values were significantly higher for males than for females, but differences upon age, BMI and disease severity group were not significant (at p = 0.05). Peak inspiratory flows through the inhalers (PIFdev) correlated best with their native spirometric counterparts (PIF) and linear PIFdev-PIF relationships could be determined (Breezhaler{\circledR}: r = 0.60, p = 0.002, Genuair{\circledR}: r = 0.55, p = 0.001, Turbuhaler{\circledR}: r = 0.57, p = 0.002). Physical background of the deduced equations was also provided. Conclusions: Present correlations may be used to assess the success of inhalation of COPD patients through the studied devices and to choose the appropriate device for each patient. As a consequence, the amount of the drug emitted by the device can be optimized, the deposition efficiency within the lungs increased and the related therapeutic effect improved.",
keywords = "Management of COPD patients, Patient and device specific spirometric parameters, Personalized device selection",
author = "{\'A}rp{\'a}d Farkas and Annam{\'a}ria Szipőcs and Alp{\'a}r Horv{\'a}th and I. Horv{\'a}th and Gabriella G{\'a}lffy and J{\'a}nos Varga and Krist{\'o}f Galambos and Szilvia Kugler and A. Nagy and Zsuzsanna Szalai",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.rmed.2019.06.021",
language = "English",
volume = "154",
pages = "133--140",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection

AU - Farkas, Árpád

AU - Szipőcs, Annamária

AU - Horváth, Alpár

AU - Horváth, I.

AU - Gálffy, Gabriella

AU - Varga, János

AU - Galambos, Kristóf

AU - Kugler, Szilvia

AU - Nagy, A.

AU - Szalai, Zsuzsanna

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Introduction: Drug emission from DPIs is dependent on the inspiratory flow parameters through them, which are not directly measured by standard spirometry. Their estimation based on native spirometric data could help in choosing the appropriate device and optimizing the drug deposition. Objectives: The aim of this study was to survey patient preferences and to find correlations between breathing parameters of COPD patients through DPI devices and their baseline spirometric data, age, gender, disease severity and anthropometric characteristics. Another objective was to establish relationships between peak inspiratory flows (PIFdev) through Breezhaler®, Genuair® and Turbuhaler® inhalers and their determinants. Methods: Breathing parameters of 49 patients with previously diagnosed COPD and currently using one of the above inhalers were recorded by normal spirometry and while inhaling through the selected DPIs. Statistical analysis of the measured data was completed. All specific data are provided as (mean ± standard deviation). Results: More than 60% of the patients stated that their current device is the easiest to use. The means of the measured PIFdev values were 91.4 L/min, 77.1 L/min and 77.5 L/min for Breezhaler®, Genuair®, and Turbuhaler®, respectively. PIFdev values were significantly higher for males than for females, but differences upon age, BMI and disease severity group were not significant (at p = 0.05). Peak inspiratory flows through the inhalers (PIFdev) correlated best with their native spirometric counterparts (PIF) and linear PIFdev-PIF relationships could be determined (Breezhaler®: r = 0.60, p = 0.002, Genuair®: r = 0.55, p = 0.001, Turbuhaler®: r = 0.57, p = 0.002). Physical background of the deduced equations was also provided. Conclusions: Present correlations may be used to assess the success of inhalation of COPD patients through the studied devices and to choose the appropriate device for each patient. As a consequence, the amount of the drug emitted by the device can be optimized, the deposition efficiency within the lungs increased and the related therapeutic effect improved.

AB - Introduction: Drug emission from DPIs is dependent on the inspiratory flow parameters through them, which are not directly measured by standard spirometry. Their estimation based on native spirometric data could help in choosing the appropriate device and optimizing the drug deposition. Objectives: The aim of this study was to survey patient preferences and to find correlations between breathing parameters of COPD patients through DPI devices and their baseline spirometric data, age, gender, disease severity and anthropometric characteristics. Another objective was to establish relationships between peak inspiratory flows (PIFdev) through Breezhaler®, Genuair® and Turbuhaler® inhalers and their determinants. Methods: Breathing parameters of 49 patients with previously diagnosed COPD and currently using one of the above inhalers were recorded by normal spirometry and while inhaling through the selected DPIs. Statistical analysis of the measured data was completed. All specific data are provided as (mean ± standard deviation). Results: More than 60% of the patients stated that their current device is the easiest to use. The means of the measured PIFdev values were 91.4 L/min, 77.1 L/min and 77.5 L/min for Breezhaler®, Genuair®, and Turbuhaler®, respectively. PIFdev values were significantly higher for males than for females, but differences upon age, BMI and disease severity group were not significant (at p = 0.05). Peak inspiratory flows through the inhalers (PIFdev) correlated best with their native spirometric counterparts (PIF) and linear PIFdev-PIF relationships could be determined (Breezhaler®: r = 0.60, p = 0.002, Genuair®: r = 0.55, p = 0.001, Turbuhaler®: r = 0.57, p = 0.002). Physical background of the deduced equations was also provided. Conclusions: Present correlations may be used to assess the success of inhalation of COPD patients through the studied devices and to choose the appropriate device for each patient. As a consequence, the amount of the drug emitted by the device can be optimized, the deposition efficiency within the lungs increased and the related therapeutic effect improved.

KW - Management of COPD patients

KW - Patient and device specific spirometric parameters

KW - Personalized device selection

UR - http://www.scopus.com/inward/record.url?scp=85067824940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067824940&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.06.021

DO - 10.1016/j.rmed.2019.06.021

M3 - Article

AN - SCOPUS:85067824940

VL - 154

SP - 133

EP - 140

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -